🔗 Share this article

This year's prestigious award in medical science has been awarded for transformative findings that clarify how the body's defense network targets harmful pathogens while sparing the healthy tissues.

A trio of renowned scientists—Japan's Shimon Sakaguchi and American experts Dr. Brunkow and Fred Ramsdell—share this honor.

Their work uncovered specialized "security guards" within the immune system that remove rogue defense cells that could attacking the organism.

These discoveries are now enabling innovative treatments for autoimmune diseases and cancer.

The winners will share a prize fund worth 11m SEK.

Decisive Findings

"Their research has been essential for comprehending how the immune system operates and the reason we do not all suffer from severe self-attack conditions," commented the chair of the Nobel Committee.

This team's research explain a fundamental mystery: In what way does the defense system defend us from numerous infections while keeping our own tissues intact?

The immune system uses immune cells that search for indicators of disease, even viruses and bacteria it has not met before.

These defenders utilize sensors—called receptors—that are produced randomly in a vast number of combinations.

This provides the defense network the ability to fight a broad range of invaders, but the randomness of the mechanism inevitably creates white blood cells that may target the body.

Security Guards of the Body

Scientists earlier understood that a portion of these harmful white blood cells were eliminated in the immune organ—where white blood cells develop.

The latest award recognizes the discovery of T-reg cells—described as the body's "peacekeepers"—which travel through the body to disarm any immune cells that attack the healthy cells.

We know that this process malfunctions in self-attack conditions such as juvenile diabetes, MS, and RA.

The Nobel panel added, "The findings have established a novel area of research and accelerated the development of new therapies, for example for cancer and immune disorders."

Regarding malignancies, T-regs prevent the body from fighting the growth, so research are aimed at lowering their quantity.

For self-attack disorders, experiments are exploring boosting T-reg cells so the body is no longer under attack. A comparable method could also be useful in reducing the chances of organ transplant rejection.

Innovative Studies

Professor Shimon Sakaguchi, from Osaka University, conducted tests on mice that had their thymus extracted, leading to autoimmune disease.

He showed that injecting defense cells from other animals could prevent the illness—suggesting there was a mechanism for blocking defenders from harming the body.

Mary Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were studying an genetic autoimmune disease in rodents and humans that resulted in the identification of a gene vital for the way regulatory T-cells operate.

"Their pioneering research has uncovered how the body's defenses is kept in check by regulatory T cells, preventing it from accidentally attacking the healthy cells," said a prominent biological science expert.

"The research is a remarkable example of how fundamental physiological study can have broad implications for human health."